INDIVIOR PHARMACEUTICALS INC (INDV) Forecast, Price Target & Analyst Ratings

NASDAQ:INDV • US45579U1097

Current stock price

31.6 USD
+1.06 (+3.47%)
At close:
32.21 USD
+0.61 (+1.93%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INDIVIOR PHARMACEUTICALS INC (INDV).

Forecast Snapshot

Consensus Price Target

Price Target
$47.79
+ 51.25% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 23, 2026
Period
Q1 / 2026
EPS Estimate
$0.67
Revenue Estimate
278.09M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
84.62%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$47.79
Upside
+ 51.25%
From current price of $31.60 to mean target of $47.79, Based on 13 analyst forecasts
Low
$39.39
Median
$48.96
High
$56.70

Price Target Revisions

1 Month
2.82%
3 Months
23.77%

Price Target Summary

13 Wall Street analysts provided a forecast for the next 12 months for INDV. The average price target is 47.79 USD. This implies a price increase of 51.25% is expected in the next year compared to the current price of 31.6.
The average price target has been revised upward by 23.77% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

INDV Current Analyst RatingINDV Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

INDV Historical Analyst RatingsINDV Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
84.62%
INDV was analyzed by 13 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about INDV.
In the previous month the buy percentage consensus was at a similar level.
INDV was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-01-12HC Wainwright & Co.Maintains Buy -> Buy
2025-10-31Piper SandlerReiterate Overweight -> Overweight
2025-10-30HC Wainwright & Co.Maintains Buy -> Buy
2025-08-27Craig-HallumMaintains Buy -> Buy
2025-08-06HC Wainwright & Co.Initiate Buy
2025-06-30Craig-HallumMaintains Buy -> Buy
2025-03-06Piper SandlerMaintains Overweight -> Overweight
2024-10-25Piper SandlerReiterate Overweight -> Overweight
2024-10-11Piper SandlerReiterate Overweight -> Overweight
2024-10-11Craig-HallumMaintains Buy -> Buy
2024-09-13Piper SandlerReiterate Overweight -> Overweight
2024-07-23Piper SandlerInitiate Overweight
2024-07-10Craig-HallumMaintains Buy -> Buy
2024-04-03Craig-HallumInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 23, 2026
Period
Q1 / 2026
EPS Estimate
$0.67
Revenue Estimate
278.09M
Revenue Q2Q
4.55%
EPS Q2Q
62.95%
Number of Analysts
7

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

INDV is expected to report earnings on 4/23/2026. The consensus EPS estimate for the next earnings is 0.67 USD and the consensus revenue estimate is 278.09M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2029

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
INDV revenue by date.INDV revenue by date.
901M
13.91%		1.093B
21.31%		1.188B
8.69%		1.215B
2.27%		1.183B
-2.63%		1.245B
5.24%		1.328B
6.67%		1.254B
-5.57%
EBITDA
YoY % growth
INDV ebitda by date.INDV ebitda by date.
237M
3.95%		290M
22.36%		316M
8.97%		404.87M
28.12%		531.03M
31.16%		573.88M
8.07%		616.63M
7.45%		430.26M
-30.22%
EBIT
YoY % growth
INDV ebit by date.INDV ebit by date.
221M
7.28%		275M
24.43%		287M
4.36%		376.64M
31.23%		529.87M
40.68%		573.32M
8.20%		626.98M
9.36%		418M
-33.33%
Operating Margin
INDV operating margin by date.INDV operating margin by date.
24.53%25.16%24.16%31.00%44.79%46.05%47.21%33.33%
EPS
YoY % growth
INDV eps by date.INDV eps by date.
N/A
48.56%		N/A
29.17%		0.44
-69.62%		2.40
459.09%		3.15
27.98%		3.49
10.96%		3.88
11.12%		2.17
-44.06%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		0.67
62.95%		0.76
49.00%		0.80
11.56%		0.88
6.98%		0.79
18.32%		0.89
17.45%		0.94
16.83%		0.99
13.37%		0.88
10.97%		0.94
5.14%		1.03
9.78%		1.10
10.77%
Revenue
Q2Q % growth		278.09M
4.55%		289.19M
-4.24%		298.55M
-4.92%		311.26M
-13.06%		291.45M
4.80%		308.82M
6.79%		318.27M
6.61%		329.83M
5.97%		330.48M
13.39%		342.52M
10.91%		355.37M
11.66%		369.85M
12.13%
EBITDA
Q2Q % growth		117.56M
63.28%		130.97M
70.09%		152.8M
199.61%		162.79M
28.50%		143.16M
21.78%		151.22M
15.46%		156.16M
2.20%		159.99M
-1.72%		150.25M
4.95%		161.77M
6.98%		176.05M
12.74%		188.5M
17.82%
EBIT
Q2Q % growth		115.34M
72.15%		128.09M
77.90%		135.56M
215.26%		147.9M
36.30%		128.21M
11.16%		143.62M
12.12%		151.67M
11.88%		160.6M
8.59%		148M
15.44%		159.53M
11.08%		173.81M
14.60%		186.25M
15.97%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

INDV Yearly Revenue VS EstimatesINDV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
INDV Yearly EPS VS EstimatesINDV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 1 2 3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
16.42%
EPS Next 5 Year
-3.07%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
3.01%
Revenue Next 5 Year
0.79%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
149.29%
EBIT Next 5 Year
64.69%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

INDIVIOR PHARMACEUTICALS INC / INDV Forecast FAQ

What is the price target for INDV stock?

13 analysts have analysed INDV and the average price target is 47.79 USD. This implies a price increase of 51.25% is expected in the next year compared to the current price of 31.6.

What is the next earnings date for INDV stock?

INDIVIOR PHARMACEUTICALS INC (INDV) will report earnings on 2026-04-23.

What are the consensus estimates for INDIVIOR PHARMACEUTICALS INC (INDV) next earnings?

The consensus EPS estimate for the next earnings of INDIVIOR PHARMACEUTICALS INC (INDV) is 0.67 USD and the consensus revenue estimate is 278.09M USD.

What is the expected long term growth rate for INDV stock?

The expected long term growth rate for INDIVIOR PHARMACEUTICALS INC (INDV) is 3.01%.